info@p-95.com

proposal request

Clinical Trial Delivery

Comprehensive Clinical Trial Support for Vaccines and Infectious Disease.

Data, Analysis and writing

Our data management, biostatistics, safety management and medical writing teams ensure data integrity and insightful analysis for vaccines and drugs across all stages of development.

Epidemiology and Real-World Evidence (RWE) Solutions

Comprehensive Epidemiology and RWE solutions for Vaccines and Infectious Diseases.

Africa and LMICs

Expanding Clinical and Epidemiological Horizons: Expertise in Africa, LMICs, and Beyond.

VIEW ALL SERVICES

All News

Read Article

Read Article

News

P95 featured in the GIZ’s 2021 Integrated Company Report

By P95

November 2, 2022

The Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH‘s 2021 Integrated Company Report highlights the international training program to enhance vaccine pharmacovigilance capacity in low and middle-income countries developed last year as a joint effort between P95 and GIZ. Through this initiative, our company contributed its knowledge and expertise on pharmacovigilance and vaccine safety and effectiveness studies, while GIZ provided support to roll out of the training through an international network, which included health agencies and experts from Ecuador, Ghana and Morocco.
You can find more on this initiative, featuring our team lead Zuleika Aponte (she/her/ella/elle), here: https://reporting.giz.de/2021/our-work-around-the-world/global-health/greater-vaccination-safety

P95

Pioneering Clinical Excellence in Vaccines and Infectious Diseases

Tags:

0 Comments

You May Also Like

P95’s Journey From Epidemiology Consulting to Comprehensive CRO

P95’s Journey From Epidemiology Consulting to Comprehensive CRO

Apr 12 |

In a recent interview for Ampersand Capital Partners, our CEO, Thomas Verstraeten, and Chairman, Benoit Bouche shared pivotal insights into P95’s growth from an epidemiology consulting into a global comprehensive Contract Research Organization (CRO).

Almost one year from P95’s partnership with Ampersand Capital Partners, the article dives deeper into P95’s expanding global reach, client-focused capabilities, and commitment to global health that bring our company to the forefront.